Siderophore-mediated iron acquisition and modulation of host-bacterial interactions

Free Radical Biology and Medicine

Volumn 105, Issue , 2017, Pages 68-78

  Ellermann, Melissa ^a   Arthur, Janelle C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Host microbial interactions; Infection; Inflammation; Intestinal microbiota; Iron homoestasis; Siderophore

Indexed keywords

IRON; SIDEROPHORE;

BACTERIAL VIRULENCE; COLORECTAL CANCER; HOMEOSTASIS; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE; MICROBIAL COMMUNITY; MODULATION; MOLECULAR DYNAMICS; ORGANISMAL INTERACTION; PREDATION; PRIORITY JOURNAL; REVIEW; ANIMAL; GASTROINTESTINAL TRACT; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL MUCOSA; IRON; MICROBIAL INTERACTIONS; SIDEROPHORES;

EID: 85005963697     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.10.489     Document Type: Review

References (141)

1. [1] Costello, E.K., Lauber, C.L., Hamady, M., Fierer, N., Gordon, J.I., Knight, R., Bacterial community variation in human body habitats across space and time. Science 326 (2009), 1694–1697, 10.1126/science.1177486.
2. [2] Human Microbiome Project Consortium, Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214, 10.1038/nature11234.
3. [3] Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. 108:Suppl 1 (2011), S4578–S4585, 10.1073/pnas.1000081107.
4. [4] Subramanian, S., Huq, S., Yatsunenko, T., Haque, R., Mahfuz, M., Alam, M.A., et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature, 2014, 10.1038/nature13421.
5. [5] Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638, 10.1126/science.1110591.
6. [6] David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2013), 559–563, 10.1038/nature12820.
7. [7] Org, E., Parks, B.W., Joo, J.W.J., Emert, B., Schwartzman, W., Kang, E.Y., et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 25 (2015), 1558–1569, 10.1101/gr.194118.115.
8. [8] Carmody, R.N., Gerber, G.K., Luevano, J.M., Gatti, D.M., Somes, L., Svenson, K.L., et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 17 (2015), 72–84, 10.1016/j.chom.2014.11.010.
9. [9] Goodrich, J.K., Davenport, E.R., Waters, J.L., Clark, A.G., Ley, R.E., Cross-species comparisons of host genetic associations with the microbiome. Science 352 (2016), 532–535, 10.1126/science.aad9379.
10. [10] Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564, 10.1126/science.aad3503.
11. [11] Zhernakova, A., Kurilshikov, A., Bonder, M.J., Tigchelaar, E.F., Schirmer, M., Vatanen, T., et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352 (2016), 565–569, 10.1126/science.aad3369.
12. [12] Zoetendal, E.G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A.D.L., de Vos, W.M., Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 68 (2002), 3401–3407, 10.1128/aem.68.7.3401-3407.2002.
13. [13] Zhang, Z., Geng, J., Tang, X., Fan, H., Xu, J., Wen, X., et al. Spatial heterogeneity and co-occurrence patterns of human mucosal-associated intestinal microbiota. ISME J. 8 (2014), 881–893, 10.1038/ismej.2013.185.
14. [14] Li, H., Limenitakis, J.P., Fuhrer, T., Geuking, M.B., Lawson, M.A., Wyss, M., et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat. Commun. 6 (2015), 1–13, 10.1038/ncomms9292.
15. [15] Chow, J., Lee, S.M., Shen, Y., Khosravi, A., Mazmanian, S.K., Host-bacterial symbiosis in health and disease. Adv. Immunol. 107 (2010), 243–274, 10.1016/B978-0-12-381300-8.00008-3.
16. [16] Belkaid, Y., Hand, T.W., Role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141, 10.1016/j.cell.2014.03.011.
17. [17] Gensollen, T., Iyer, S.S., Kasper, D.L., Blumberg, R.S., How colonization by microbiota in early life shapes the immune system. Science 352 (2016), 539–544, 10.1126/science.aad9378.
18. [18] Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16 (2016), 341–352, 10.1038/nri.2016.42.
19. [19] Gomez de Agüero, M., Ganal-Vonarburg, S.C., Fuhrer, T., Rupp, S., Uchimura, Y., Li, H., et al. The maternal microbiota drives early postnatal innate immune development. Science 351 (2016), 1296–1302, 10.1126/science.aad2571.
20. [20] Cockburn, D.W., Koropatkin, N.M., Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease. J. Mol. Biol. 428 (2016), 3230–3252, 10.1016/j.jmb.2016.06.021.
21. [21] Wahlström, A., Sayin, S.I., Marschall, H.-U., Bäckhed, F., Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24 (2016), 41–50, 10.1016/j.cmet.2016.05.005.
22. [22] Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9 (2012), 599–608, 10.1038/nrgastro.2012.152.
23. [23] Sartor, R.B., Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008), 577–594, 10.1053/j.gastro.2007.11.059.
24. [24] Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermu'dez-Humara'n, L.G., Gratadoux, J.-J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. 105 (2008), 16731–16736, 10.1073/pnas.0804812105.
25. [25] Llopis, M., Antolín, M., Carol, M., Borruel, N., Casellas, F., Martinez, C., et al. Lactobacillus casei downregulates commensals’ inflammatory signals in Crohn's disease mucosa. Inflamm. Bowel Dis. 15 (2009), 275–283, 10.1002/ibd.20736.
26. [26] Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331 (2011), 337–341, 10.1126/science.1198469.
27. [27] Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236, 10.1038/nature12331.
28. [28] Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573, 10.1126/science.1241165.
29. [29] Eun, C.S., Mishima, Y., Wohlgemuth, S., Liu, B., Bower, M., Carroll, I.M., et al. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10−/− mice. Infect. Immun. 82 (2014), 2239–2246, 10.1128/IAI.01513-13.
30. [30] Moschen, A.R., Gerner, R.R., Wang, J., Klepsch, V., Adolph, T.E., Reider, S.J., et al. Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe 19 (2016), 455–469, 10.1016/j.chom.2016.03.007.
31. [31] Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol., 13, 2012, R79, 10.1186/gb-2012-13-9-r79.
32. [32] Arthur, J.C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.-J., et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123, 10.1126/science.1224820.
33. [33] Schwabe, R.F., Jobin, C., The microbiome and cancer. Nat. Rev. Cancer 13 (2013), 800–812, 10.1038/nrc3610.
34. [34] Gevers, D., Kugathasan, S., Denson, L.A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392, 10.1016/j.chom.2014.02.005.
35. [35] Pamer, E.G., Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 352 (2016), 535–538, 10.1126/science.aad9382.
36. [36] Evstatiev, R., Gasche, C., Iron sensing and signalling. Gut 61 (2012), 933–952, 10.1136/gut.2010.214312.
37. [37] Miethke, M., Marahiel, M.A., Siderophore-based iron acquisition and pathogen control. Microbiol. Mol. Biol. Rev. 71 (2007), 413–451, 10.1128/MMBR.00012-07.
38. [38] Chu, B.C., Garcia-Herrero, A., Johanson, T.H., Krewulak, K.D., Lau, C.K., Peacock, R.S., et al. Siderophore uptake in bacteria and the battle for iron with the host; a bird's eye view. Biometals 23 (2010), 601–611, 10.1007/s10534-010-9361-x.
39. [39] Sheldon, J.R., Heinrichs, D.E., Recent developments in understanding the iron acquisition strategies of gram positive pathogens. FEMS Microbiol. Rev. 39 (2015), 592–630, 10.1093/femsre/fuv009.
40. [40] Holden, V.I., Bachman, M.A., Diverging roles of bacterial siderophores during infection. Metallomics 7 (2015), 986–995, 10.1039/C4MT00333K.
41. [41] Andrews, S.C., Robinson, A.K., Rodriguez-Quinones, F., Bacterial iron homeostasis. FEMS Microbiol. Rev. 27 (2003), 215–237, 10.1016/S0168-6445(03)00055-X.
42. [42] Troxell, B., Hassan, H.M., Transcriptional regulation by Ferric Uptake Regulator (Fur) in pathogenic bacteria. Front. Cell. Infect. Microbiol., 3, 2013, 59, 10.3389/fcimb.2013.00059.
43. [43] McHugh, J.P., Rodríguez-Quinoñes, F., Abdul-Tehrani, H., Svistunenko, D.A., Poole, R.K., Cooper, C.E., et al. Global iron-dependent gene regulation in Escherichia coli. A new mechanism for iron homeostasis. J. Biol. Chem. 278 (2003), 29478–29486, 10.1074/jbc.M303381200.
44. [44] Seo, S.W., Kim, D., Latif, H., O'Brien, E.J., Szubin, R., Palsson, B.O., Deciphering Fur transcriptional regulatory network highlights its complex role beyond iron metabolism in Escherichia coli. Nat. Commun., 5, 2014, 4910, 10.1038/ncomms5910.
45. [45] Cornelissen, C.N., Transferrin-iron uptake by gram-negative bacteria. Front. Biosci. 8 (2003), d836–d847.
46. [46] Letain, T.E., Postle, K., TonB protein appears to transduce energy by shuttling between the cytoplasmic membrane and the outer membrane in Escherichia coli. Mol. Microbiol. 24 (1997), 271–283.
47. [47] Braun, V., Hantke, K., Recent insights into iron import by bacteria. Curr. Opin. Chem. Biol. 15 (2011), 328–334, 10.1016/j.cbpa.2011.01.005.
48. [48] Kammler, M., Schön, C., Hantke, K., Characterization of the ferrous iron uptake system of Escherichia coli. J. Bacteriol. 175 (1993), 6212–6219.
49. [49] Sabri, M., Léveillé, S., Dozois, C.M., SitABCD, A., Homologue from an avian pathogenic Escherichia coli strain mediates transport of iron and manganese and resistance to hydrogen peroxide. Microbiology 152 (2006), 745–758, 10.1099/mic.0.28682-0.
50. [50] Hider, R.C., Kong, X., Chemistry and biology of siderophores. Nat. Prod. Rep., 27, 2010, 637, 10.1039/b906679a.
51. [51] Bachman, M.A., Lenio, S., Schmidt, L., Oyler, J.E., Weiser, J.N., Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. mBio, 3, 2012, 10.1128/mBio.00224-11.
52. [52] Deriu, E., Liu, J.Z., Pezeshki, M., Edwards, R.A., Ochoa, R.J., Contreras, H., et al. Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14 (2013), 26–37, 10.1016/j.chom.2013.06.007.
53. [53] Fischbach, M.A., Lin, H., Liu, D.R., Walsh, C.T., How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat. Chem. Biol. 2 (2006), 132–138, 10.1038/nchembio771.
54. [54] Garcia, E.C., Brumbaugh, A.R., Mobley, H.L.T., Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 79 (2011), 1225–1235, 10.1128/IAI.01222-10.
55. [55] Watts, R.E., Totsika, M., Challinor, V.L., Mabbett, A.N., Ulett, G.C., Voss, J.J. De, et al. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 80 (2011), 333–344, 10.1128/IAI.05594-11.
56. [56] Stein, J., Hartmann, F., Dignass, A.U., Diagnosis and management of iron deficiency anemia in patients with IBD. Nat. Rev. Gastroenterol. Hepatol. 7 (2010), 599–610, 10.1038/nrgastro.2010.151.
57. [57] Lund, E.K., Wharf, S.G., Fairweather-Tait, S.J., Johnson, I.T., Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am. J. Clin. Nutr. 69 (1999), 250–255.
58. [58] Carrier, J., Aghdassi, E., Platt, I., Cullen, J., Allard, J.P., Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment. Pharm. Ther. 15 (2001), 1989–1999.
59. [59] Werner, T., Wagner, S.J., Martínez, I., Walter, J., Chang, J.-S., Clavel, T., et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 60 (2011), 325–333, 10.1136/gut.2010.216929.
60. [60] Deschemin, J.C., Noordine, M.L., Remot, A., Willemetz, A., Afif, C., Canonne-Hergaux, F., et al. The microbiota shifts the iron sensing of intestinal cells. FASEB J., 2015, 10.1096/fj.15-276840.
61. [61] Lee, T., Clavel, T., Smirnov, K., Schmidt, A., Lagkouvardos, I., Walker, A., et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut, 2016, 10.1136/gutjnl-2015-309940.
62. [62] Flo, T.H., Smith, K.D., Sato, S., Rodriguez, D.J., Holmes, M.A., Strong, R.K., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 (2004), 917–921, 10.1038/nature03104.
63. [63] Raffatellu, M., George, M.D., Akiyama, Y., Hornsby, M.J., Nuccio, S.-P., Paixao, T.A., et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe(5), 2009, 476–486, 10.1016/j.chom.2009.03.011.
64. [64] Yen, C.-C., Shen, C.-J., Hsu, W.-H., Chang, Y.-H., Lin, H.-T., Chen, H.-L., et al. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. Biometals 24 (2011), 585–594, 10.1007/s10534-011-9423-8.
65. [65] Kane, S.V., Sandborn, W.J., Rufo, P.A., Zholudev, A., Boone, J., Lyerly, D., et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am. J. Gastroenterol. 98 (2003), 1309–1314, 10.1111/j.1572-0241.2003.07458.x.
66. [66] Chassaing, B., Srinivasan, G., Delgado, M.A., Young, A.N., Gewirtz, A.T., Vijay-Kumar, M., Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One, 7, 2012, e44328, 10.1371/journal.pone.0044328.
67. [67] Behnsen, J., Jellbauer, S., Wong, C.P., Edwards, R.A., George, M.D., Ouyang, W., et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity 40 (2014), 262–273, 10.1016/j.immuni.2014.01.003.
68. [68] Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004), 2090–2093, 10.1126/science.1104742.
69. [69] Wang, L., Harrington, L., Trebicka, E., Shi, H.N., Kagan, J.C., Hong, C.C., et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J. Clin. Invest., 2009, 10.1172/JCI39939DS1.
70. [70] Wang, L., Trebicka, E., Fu, Y., Ellenbogen, S., Hong, C.C., Babitt, J.L., et al. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm. Bowel Dis. 18 (2012), 112–119, 10.1002/ibd.21675.
71. [71] Shanmugam, N.K.N., Trebicka, E., Fu, L.-L., Shi, H.N., Cherayil, B.J., Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota. J. Immunol. 193 (2014), 1398–1407, 10.4049/jimmunol.1400278.
72. [72] Pi, H., Jones, S.A., Mercer, L.E., Meador, J.P., Caughron, J.E., Jordan, L., et al. Role of catecholate siderophores in gram-negative bacterial colonization of the mouse gut. PLoS One, 7, 2012, e50020, 10.1371/journal.pone.0050020.
73. [73] Torres, A.G., Cieza, R.J., Rojas-Lopez, M., Blumentritt, C.A., Souza, C.S., Johnston, R.K., et al. In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infection. BMC Microbiol., 12, 2012, 112, 10.1186/1471-2180-12-112.
74. [74] Arthur, J.C., Gharaibeh, R.Z., Mühlbauer, M., Perez-Chanona, E., Uronis, J.M., McCafferty, J., et al. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat. Commun., 5, 2014, 4724, 10.1038/ncomms5724.
75. [75] Jacobi, C.A., Gregor, S., Rakin, A., Heesemann, J., Expression analysis of the yersiniabactin receptor gene fyuA and the heme receptor hemR of Yersinia enterocolitica in vitro and in vivo using the reporter genes for green fluorescent protein and luciferase. Infect. Immun. 69 (2001), 7772–7782, 10.1128/IAI.69.12.7772-7782.2001.
76. [76] Searle, L.J., Méric, G., Porcelli, I., Sheppard, S.K., Lucchini, S., Variation in siderophore biosynthetic gene distribution and production across environmental and faecal populations of Escherichia coli. PLoS One, 10, 2015, e0117906, 10.1371/journal.pone.0117906.
77. [77] Nowrouzian, F.L., Adlerberth, I., Wold, A.E., Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect. 8 (2006), 834–840, 10.1016/j.micinf.2005.10.011.
78. [78] Dogan, B., Suzuki, H., Herlekar, D., Sartor, R.B., Campbell, B.J., Roberts, C.L., et al. Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation. Inflamm. Bowel Dis. 20 (2014), 1919–1932, 10.1097/MIB.0000000000000183.
79. [79] Nowrouzian, F.L., Wold, A.E., Adlerberth, I., Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J. Infect. Dis. 191 (2005), 1078–1083, 10.1086/427996.
80. [80] Zimmermann, M.B., Chassard, C., Rohner, F., N'Goran, E.K., Nindjin, C., Dostal, A., et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am. J. Clin. Nutr. 92 (2010), 1406–1415, 10.3945/ajcn.110.004564.
81. [81] Dostal, A., Chassard, C., Hilty, F.M., Zimmermann, M.B., Jaeggi, T., Rossi, S., et al. Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J. Nutr. 142 (2012), 271–277, 10.3945/jn.111.148643.
82. [82] Krebs, N.F., Sherlock, L.G., Westcott, J., Culbertson, D., Hambidge, K.M., Feazel, L.M., et al. Effects of different complementary feeding regimens on iron status and enteric microbiota in breastfed infants. J. Pediatr. 163 (2013), 416–423, 10.1016/j.jpeds.2013.01.024.
83. [83] Jaeggi, T., Kortman, G.A.M., Moretti, D., Chassard, C., Holding, P., Dostal, A., et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut, 2014, 10.1136/gutjnl-2014-307720.
84. [84] Pereira, D.I.A., Aslam, M.F., Frazer, D.M., Schmidt, A., Walton, G.E., McCartney, A.L., et al. Dietary iron depletion at weaning imprints low microbiome diversity and this is not recovered with oral nano Fe(III). MicrobiologyOpen 4 (2014), 12–27, 10.1002/mbo3.213.
85. [85] Dostal, A., Lacroix, C., Pham, V.T., Zimmermann, M.B., Del'homme, C., Bernalier-Donadille, A., et al. Iron supplementation promotes gut microbiota metabolic activity but not colitis markers in human gut microbiota-associated rats. Br. J. Nutr. 111 (2014), 2135–2145, 10.1017/S000711451400021X.
86. [86] Dostal, A., Fehlbaum, S., Chassard, C., Zimmermann, M.B., Lacroix, C., Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites. FEMS Microbiol. Ecol. 83 (2013), 161–175, 10.1111/j.1574-6941.2012.01461.x.
87. [87] Dostal, A., Lacroix, C., Bircher, L., Pham, V.T., Follador, R., Zimmermann, M.B., et al. Iron modulates butyrate production by a child gut microbiota in vitro. mBio(6), 2015, e01453–15, 10.1128/mBio.01453-15.
88. [88] Ettreiki, C., Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents. World J. Gastroenterol., 18, 2012, 2619, 10.3748/wjg.v18.i21.2619.
89. [89] Vazquez-Gutierrez, P., Lacroix, C., Jaeggi, T., Zeder, C., Zimmerman, M.B., Chassard, C., Bifidobacteria strains isolated from stools of iron deficient infants can efficiently sequester iron. BMC Microbiol., 15, 2015, 3, 10.1186/s12866-014-0334-z.
90. [90] Kortman, G.A.M., Dutilh, B.E., Maathuis, A.J.H., Engelke, U.F., Boekhorst, J., Keegan, K.P., et al. Microbial metabolism shifts towards an adverse profile with supplementary iron in the TIM-2 in vitro model of the human colon. Front. Microbiol., 6, 2015, 1481, 10.3389/fmicb.2015.01481.
91. [91] Caldwell, D.R., Arcand, C., Inorganic and metal-organic growth requirements of the genus Bacteroides. J. Bacteriol. 120 (1974), 322–333.
92. [92] Sperry, J.F., Appleman, M.D., Wilkins, T.D., Requirement of heme for growth of Bacteroides fragilis. Appl. Environ. Microbiol. 34 (1977), 386–390.
93. [93] Rocha, E.R., de Uzeda, M., Brock, J.H., Effect of ferric and ferrous iron chelators on growth of Bacteroides fragilis under anaerobic conditions. FEMS Microbiol. Lett. 68 (1991), 45–50.
94. [94] Koh, A., De Vadder, F., Kovatcheva-Datchary, P., Bäckhed, F., From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165 (2016), 1332–1345, 10.1016/j.cell.2016.05.041.
95. [95] Bultman, S.J., The microbiome and its potential as a cancer preventive intervention. Semin. Oncol. 43 (2016), 97–106, 10.1053/j.seminoncol.2015.09.001.
96. [96] Valdebenito, M., Crumbliss, A.L., Winkelmann, G., Hantke, K., Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int. J. Med. Microbiol. 296 (2006), 513–520, 10.1016/j.ijmm.2006.06.003.
97. [97] Tsolis, R.M., Bäumler, A.J., Heffron, F., Stojiljkovic, I., Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse. Infect. Immun. 64 (1996), 4549–4556.
98. [98] Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N., Strong, R.K., The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10 (2002), 1033–1043.
99. [99] Fischbach, M.A., Lin, H., Zhou, L., Yu, Y., Abergel, R.J., Liu, D.R., et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl. Acad. Sci. USA 103 (2006), 16502–16507, 10.1073/pnas.0604636103.
100. [100] Steigedal, M., Marstad, A., Haug, M., Damås, J.K., Strong, R.K., Roberts, P.L., et al. Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. J. Immunol. 193 (2014), 6081–6089, 10.4049/jimmunol.1401528.
101. [101] Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.-L., Barnich, N., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127 (2004), 412–421.
102. [102] Kim, S.C., Tonkonogy, S.L., Albright, C.A., Tsang, J., Balish, E.J., Braun, J., et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128 (2005), 891–906.
103. [103] Rolhion, N., Darfeuille-Michaud, A., Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm. Bowel Dis. 13 (2007), 1277–1283, 10.1002/ibd.20176.
104. [104] Low, D., Tran, H.T., Lee, I.-A., Dreux, N., Kamba, A., Reinecker, H.C., et al. Chitin-binding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis. Gastroenterology, 145, 2013, 602, 10.1053/j.gastro.2013.05.017.
105. [105] Carvalho, F.A., Barnich, N., Sivignon, A., Darcha, C., Chan, C.H.F., Stanners, C.P., et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J. Exp. Med. 206 (2009), 2179–2189, 10.1371/journal.pone.0002040.
106. [106] Carvalho, F.A., Barnich, N., Sauvanet, P., Darcha, C., Gelot, A., Darfeuille-Michaud, A., Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm. Bowel Dis. 14 (2008), 1051–1060, 10.1002/ibd.20423.
107. [107] Small, C.-L.N., Reid-Yu, S.A., McPhee, J.B., Coombes, B.K., Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat. Commun., 4, 2013, 1957, 10.1038/ncomms2957.
108. [108] Bachman, M.A., Oyler, J.E., Burns, S.H., Caza, M., Lépine, F., Dozois, C.M., et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun. 79 (2011), 3309–3316, 10.1128/IAI.05114-11.
109. [109] Rebuffat, S., Microcins in action: amazing defence strategies of Enterobacteria. Biochem. Soc. Trans. 40 (2012), 1456–1462, 10.1042/BST20120183.
110. [110] Braun, V., Pramanik, A., Gwinner, T., Köberle, M., Bohn, E., Sideromycins: tools and antibiotics. Biometals 22 (2009), 3–13, 10.1007/s10534-008-9199-7.
111. [111] Górska, A., Sloderbach, A., Marszałł, M.P., Siderophore–drug complexes: potential medicinal applications of the “Trojan horse” strategy. Trends Pharmacol. Sci. 35 (2014), 442–449, 10.1016/j.tips.2014.06.007.
112. [112] Lopez, F.E., Vincent, P.A., Zenoff, A.M., Salomón, R.A., Farías, R.N., Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection. J. Antimicrob. Chemother. 59 (2007), 676–680, 10.1093/jac/dkm009.
113. [113] Pramanik, A., Stroeher, U.H., Krejci, J., Standish, A.J., Bohn, E., Paton, J.C., et al. Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae. Int. J. Med. Microbiol. 297 (2007), 459–469, 10.1016/j.ijmm.2007.03.002.
114. [114] Kullik, I., Toledano, M.B., Tartaglia, L.A., Storz, G., Mutational analysis of the redox-sensitive transcriptional regulator OxyR: regions important for oxidation and transcriptional activation. J. Bacteriol. 177 (1995), 1275–1284.
115. [115] Cover, T.L., Peek, R.M., Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes 4 (2013), 482–493, 10.4161/gmic.26262.
116. [116] Guzzo, A., Diorio, C., DuBow, M.S., Transcription of the Escherichia coli fliC gene is regulated by metal ions. Appl. Environ. Microbiol. 57 (1991), 2255–2259.
117. [117] Brombacher, E., Baratto, A., Dorel, C., Landini, P., Gene expression regulation by the Curli activator CsgD protein: modulation of cellulose biosynthesis and control of negative determinants for microbial adhesion. J. Bacteriol. 188 (2006), 2027–2037, 10.1128/JB.188.6.2027-2037.2006.
118. [118] Wu, Y., Outten, F.W., IscR controls iron-dependent biofilm formation in Escherichia coli by regulating type I fimbria expression. J. Bacteriol. 191 (2009), 1248–1257, 10.1128/JB.01086-08.
119. [119] Noto, J.M., Gaddy, J.A., Lee, J.Y., Piazuelo, M.B., Friedman, D.B., Colvin, D.C., et al. Iron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans. J. Clin. Invest. 123 (2012), 479–492, 10.1172/JCI64373.
120. [120] Ellermann, M., Huh, E.Y., Liu, B., Carroll, I.M., Tamayo, R., Sartor, R.B., Adherent-invasive Escherichia coli production of cellulose influences iron-induced bacterial aggregation, phagocytosis, and induction of colitis. Infect. Immun. 83 (2015), 4068–4080, 10.1128/IAI.00904-15.
121. [121] Wise, A.J., Hogan, J.S., Cannon, V.B., Smith, K.L., Phagocytosis and serum susceptibility of Escherichia coil cultured in iron-deplete and iron-replete media. J. Dairy Sci. 85 (2002), 1454–1459.
122. [122] Alves, J.R., Pereira, A.C.M., Souza, M.C., Costa, S.B., Pinto, A.S., Mattos-Guaraldi, A.L., et al. Iron-limited condition modulates biofilm formation and interaction with human epithelial cells of enteroaggregative Escherichia coli (EAEC). J. Appl. Microbiol. 108 (2010), 246–255, 10.1111/j.1365-2672.2009.04417.x.
123. [123] Kortman, G.A.M., Boleij, A., Swinkels, D.W., Tjalsma, H., Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS One, 7, 2012, e29968, 10.1371/journal.pone.0029968.
124. [124] Kortman, G.A.M., Mulder, M.L.M., Richters, T.J.W., Shanmugam, N.K.N., Trebicka, E., Boekhorst, J., et al. Low dietary iron intake restrains the intestinal inflammatory response and pathology of enteric infection by food-borne bacterial pathogens. Eur. J. Immunol. 45 (2015), 2553–2567, 10.1002/eji.201545642.
125. [125] Kontoghiorghes, G.J., Kontoghiorghe, C.N., Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes. J. Drug Des. Dev. Ther., 2016, 465, 10.2147/DDDT.S79458.
126. [126] Nelson, A.L., Ratner, A.J., Barasch, J., Weiser, J.N., Interleukin-8 secretion in response to aferric enterobactin is potentiated by siderocalin. Infect. Immun. 75 (2007), 3160–3168, 10.1128/IAI.01719-06.
127. [127] Holden, V.I., Lenio, S., Kuick, R., Ramakrishnan, S.K., Shah, Y.M., Bachman, M.A., Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells. Infect. Immun. 82 (2014), 3826–3836, 10.1128/IAI.01849-14.
128. [128] Wang, L., Cherayil, B.J., Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity. J. Innate Immun. 1 (2009), 455–464, 10.1159/000210016.
129. [129] Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113 (2004), 1271–1276, 10.1172/JCI200420945.
130. [130] Drakesmith, H., Prentice, A.M., Hepcidin and the iron-infection axis. Science 338 (2012), 768–772, 10.1126/science.1224577.
131. [131] Bruick, R.K., McKnight, S.L., A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001), 1337–1340, 10.1126/science.1066373.
132. [132] Nandal, A., Ruiz, J.C., Subramanian, P., Ghimire-Rijal, S., Sinnamon, R.A., Stemmler, T.L., et al. Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. Cell Metab. 14 (2011), 647–657, 10.1016/j.cmet.2011.08.015.
133. [133] Hartmann, H., Eltzschig, H.K., Wurz, H., Hantke, K., Rakin, A., Yazdi, A.S., et al. Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology 134 (2008), 756–767, 10.1053/j.gastro.2007.12.008.
134. [134] Choi, E.-Y., Kim, E.-C., Oh, H.-M., Kim, S., Lee, H.-J., Cho, E.-Y., et al. Iron chelator triggers inflammatory signals in human intestinal epithelial cells: involvement of p38 and extracellular signal-regulated kinase signaling pathways. J. Immunol. 172 (2004), 7069–7077, 10.4049/jimmunol.172.11.7069.
135. [135] Markel, T.A., Crisostomo, P.R., Wang, M., Herring, C.M., Lahm, T., Meldrum, K.K., et al. Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling. Am. J. Physiol. Gastrointest Liver Physiol. 292 (2006), G958–G963, 10.1152/ajpgi.00502.2006.
136. [136] Lee, H.-J., Choi, S.-C., Choi, E.-Y., Lee, M.-H., Seo, G.-S., Kim, E.-C., et al. Iron chelator induces MIP-alpha/CCL20 in human intestinal epithelial cells: implication for triggering mucosal adaptive immunity. Exp. Mol. Med. 37 (2005), 297–310.
137. [137] Bachman, M.A., Miller, V.L., Weiser, J.N., Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog., 5, 2009, e1000622, 10.1371/journal.ppat.1000622.
138. [138] Paauw, A., Leverstein-van Hall, M.A., van Kessel, K.P.M., Verhoef, J., Fluit, A.C., Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells. PLoS One, 4, 2009, e8240, 10.1371/journal.pone.0008240.
139. [139] Millar, A.D., Rampton, D.S., Blake, D.R., Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment. Pharmacol. Ther. 14 (2000), 1163–1168.
140. [140] Singh, V., Yeoh, B.S., Xiao, X., Kumar, M., Bachman, M., Borregaard, N., et al. Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the inflamed gut. Nat. Commun. 6 (2015), 1–11, 10.1038/ncomms8113.
141. [141] Koh, E.-I., Henderson, J.P., Microbial copper-binding siderophores at the host-pathogen interface. J. Biol. Chem. 290 (2015), 18967–18974, 10.1074/jbc.R115.644328.